Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter study

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

(2011) P. Fenaux et al.   BLOOD

Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevance

(2011) A Thiel et al.   LEUKEMIA

Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support

(2010) Arturo Pereira et al.   AMERICAN JOURNAL OF HEMATOLOGY

Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome

(2010) A. Pellagatti et al.   BLOOD

Advances in the 5q- syndrome

(2010) J. Boultwood et al.   BLOOD

Cytogenetic features of 5q deletion and 5q− syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization

(2010) Hye Ryun Lee et al.   CANCER GENETICS AND CYTOGENETICS

WHO-defined ‘myelodysplastic syndrome with isolated del(5q)’ in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations

(2010) M M Patnaik et al.   LEUKEMIA

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

(2010) M Mallo et al.   LEUKEMIA

Cytogenetic characteristics and prognosis analysis in 231 myelodysplastic syndrome patients from a single institution

(2010) Seung-Won Jung et al.   LEUKEMIA RESEARCH

Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression

(2009) Gudrun Göhring et al.   ANNALS OF HEMATOLOGY

Cytogenetic features and prognosis analysis in Chinese patients with myelodysplastic syndrome: a multicenter study

(2009) Hong Wang et al.   ANNALS OF HEMATOLOGY

Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes

(2009) Judith Neukirchen et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression

(2009) M. Jadersten et al.   HAEMATOLOGICA

Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes

(2008) Ulrich Germing et al.   ANNALS OF HEMATOLOGY